In the last trading session, 1.45 million Palisade Bio Inc (NASDAQ:PALI) shares changed hands as the company’s beta touched 1.31. With the company’s per share price at $1.00 changed hands at $0.08 or 8.99% during last session, the market valuation stood at $2.77M. PALI’s last price was a discount, traded about -865.0% off its 52-week high of $9.65. The share price had its 52-week low at $0.75, which suggests the last value was 25.0% up since then. When we look at Palisade Bio Inc’s average trading volume, we note the 10-day average is 1.27 million shares, with the 3-month average coming to 602.93K.
Analysts gave the Palisade Bio Inc (PALI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PALI as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Palisade Bio Inc’s EPS for the current quarter is expected to be -1.99.
Palisade Bio Inc (NASDAQ:PALI) trade information
Instantly PALI was in green as seen at the end of in last trading. With action 17.94%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -39.39%, with the 5-day performance at 17.94% in the green. However, in the 30-day time frame, Palisade Bio Inc (NASDAQ:PALI) is -2.91% down. Looking at the short shares, we see there were 0.15 million shares sold at short interest cover period of 0.96 days.
The consensus price target for the stock as assigned by Wall Street analysts is 1.5, meaning bulls need an upside of 33.33% from its current market value. According to analyst projections, PALI’s forecast low is 1.5 with 1.5 as the target high. To hit the forecast high, the stock’s price needs a -50.0% plunge from its current level, while the stock would need to soar -50.0% for it to hit the projected low.
Palisade Bio Inc (PALI) estimates and forecasts
Year-over-year growth is forecast to reach -100.00% down from the last financial year.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 75.28%. The 2025 estimates are for Palisade Bio Inc earnings to increase by 56.80%, but the outlook for the next 5-year period is at 52.91% per year.
PALI Dividends
Palisade Bio Inc is expected to release its next quarterly earnings report on 2024-Nov-11.
Palisade Bio Inc (NASDAQ:PALI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.80% of Palisade Bio Inc shares while 7.20% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.26%.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . With 6.29 shares estimated at $6289.0 under it, the former controlled 0.23% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.16% of the shares, roughly 4.54 shares worth around $4536.0.
